CD133 as a marker for cancer stem cells: progresses and concerns.
about
Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like propertiesPancreatic cancer stem cell markers and exosomes - the incentive pushTargeting cancer stem cells by using the nanoparticlesLung cancer-initiating cells: a novel target for cancer therapyMetastatic cancer stem cells: from the concept to therapeuticsThe androgen receptor and stem cell pathways in prostate and bladder cancers (review)Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategiesNon-invasive in vivo imaging of tumor-associated CD133/promininCD133, Selectively Targeting the Root of CancerCodelivery of salinomycin and doxorubicin using nanoliposomes for targeting both liver cancer cells and cancer stem cellsResponse to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity.Ecto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells.Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity.Genome and transcriptome profiles of CD133-positive colorectal cancer cells.Wnt activation promotes neuronal differentiation of glioblastomaSphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell linesThe importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cellsmiR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling.Extended extraocular phenotype of PROM1 mutation in kindreds with known autosomal dominant macular dystrophy.Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.Strong expression of CD133 is associated with increased cholangiocarcinoma progressionCancer stem cell radioresistance and enrichment: where frontline radiation therapy may fail in lung and esophageal cancersIdentification of cells with colony-forming activity, self-renewal capacity, and multipotency in ovarian endometriosis.Increased CD133(+) cell infiltration in the rat brain following fluid percussion injury.Biology and flow cytometry of proangiogenic hematopoietic progenitors cells.In vitro culture of stress erythroid progenitors identifies distinct progenitor populations and analogous human progenitors.Sequential expression of putative stem cell markers in gastric carcinogenesis.Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model.Differential remodeling of extracellular matrices by breast cancer initiating cells.CD95 and CD95L promote and protect cancer stem cellsAutocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth.Establishment of pancreatic cancer stem cells by flow cytometry and their biological characteristics.Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulolobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis [corrected].Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype.Liposarcoma Cells with Aldefluor and CD133 Activity have a Cancer Stem Cell PotentialSignificance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguityOverexpression of Cell Cycle Progression Inhibitor Geminin is Associated with Tumor Stem-Like Phenotype of Triple-Negative Breast CancerEpithelial cell identity in hyperplastic precursors of breast cancer.
P2860
Q21562142-66CA307C-26CD-45A5-BEC5-B7E6457F1724Q26741215-747652F9-7FCF-4668-A211-F2C2A7204868Q26783590-0C3DB4F4-C6B4-4870-8675-53EDC501A95EQ26824222-07B447F6-2B72-4FDE-95B7-C8468C28E297Q26850739-171DB65E-6FD5-4E9B-9A45-05DDFA402394Q26853232-39AE2F2C-63D5-48AF-BF6F-A6762A554778Q26995698-23F9E80A-0D4A-4DA7-92D5-D1817440E47DQ27438105-5E23B119-EE9E-4646-90CE-997CE4BF519AQ28066353-BA15C66F-631A-4D05-A021-FBB2F94F5EADQ28315452-C4D79015-9A63-444A-B6B6-8DDE0D00942AQ31115121-C83BC34C-AA13-49BD-A2E8-BAD5013175FEQ33574875-B0F7943C-6D0E-4BC2-B21C-CAF95A63BBE0Q33586688-1C1549D3-CFFB-4DA7-A06C-4DE0D05B69F4Q33761985-345F9CA9-C428-4100-93C5-4A451CC2E13DQ33802690-13532E50-28BE-4A9F-B043-A6ED9519D467Q33855041-C817D807-8932-4F7F-852C-27A327B47D27Q33903166-044309DC-7E4A-48FF-A952-0D01EC55DE70Q33931154-5D00FA4E-4661-411C-BD88-23EACA8C07FCQ34038381-E3661451-7ADB-4BE5-A523-86D3319F0842Q34299316-4D1560DB-FD40-46D5-BFEF-84378D9A35EDQ34514940-E9B72CEF-4D9F-4953-B4CD-70EAB3594D90Q34562736-BD854480-66E4-4C6A-80D2-287493C04683Q34717467-E921D364-E462-410B-9760-8CAB6BF50715Q34985594-49164173-32B0-4DDD-911B-D18BDF99C91CQ35070528-91FB3665-C734-4A4A-99A3-A9A545BFEB9FQ35157703-A0E302C9-919C-46DD-95DA-2DA5E780E0F9Q35168107-8BBA5F25-98E0-4651-B181-FF8A2015EBBDQ35171277-DF6DC708-AA5A-467A-97FE-5734DD246025Q35287614-F5C79B64-5E0D-4A1D-BCF2-78C70EF41EB1Q35444381-5A4064B8-E358-4E41-8AFC-FE4456489696Q35544277-1622EE37-F556-474A-B8C6-1B71B74D2836Q35562681-6560F722-6D3C-4C45-B379-8305D23ED294Q35826030-6022D331-7D49-4DB2-A977-975A22BD14AEQ35855269-4E6D292D-DDA6-43D6-B42A-9857845B272CQ35866920-CDC571F2-29F9-4537-B193-367F9CF3F6DCQ35871717-A1DC1672-50D6-4EE7-8B7E-71BA5B4136BEQ35958012-5BDC83D5-9030-47CD-850E-3A79C2B16930Q36014411-827C51D3-D78A-4F65-8823-5E15A2249E72Q36092011-2D566386-B6DE-4458-B600-9A51488EE4C6Q36121103-AEBB4F7D-79C6-4474-B207-094C55CDE7AC
P2860
CD133 as a marker for cancer stem cells: progresses and concerns.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD133 as a marker for cancer stem cells: progresses and concerns.
@en
CD133 as a marker for cancer stem cells: progresses and concerns.
@nl
type
label
CD133 as a marker for cancer stem cells: progresses and concerns.
@en
CD133 as a marker for cancer stem cells: progresses and concerns.
@nl
prefLabel
CD133 as a marker for cancer stem cells: progresses and concerns.
@en
CD133 as a marker for cancer stem cells: progresses and concerns.
@nl
P356
P1476
CD133 as a marker for cancer stem cells: progresses and concerns.
@en
P2093
Philip Yuguang Wu
Yaojiong Wu
P304
P356
10.1089/SCD.2008.0338
P577
2009-10-01T00:00:00Z